ALLEGRA-D 24 HOUR OTC
Generic Name and Formulations:
Fexofenadine HCl 180mg, pseudoephedrine HCl 240mg; ext-rel tabs.
- Urate-Lowering Therapy Reduces Non-Episodic Foot Pain in Patients Without Gout Diagnosis
- IV Fluid Use Up, Narcotics Use Down in Patients With Migraine Admitted to ED
- Pregabalin and Celecoxib Reduced Need for Morphine After Lumbar Spine Surgery
Indications for ALLEGRA-D 24 HOUR:
Seasonal allergic rhinitis with nasal congestion.
Swallow whole. Take on an empty stomach. 1 tab once daily. Renal insufficiency: not recommended.
Narrow-angle glaucoma. Urinary retention. Severe hypertension or coronary artery disease. During or within 14 days of stopping MAOIs.
Hypertension. Diabetes. Ischemic heart disease. Increased intraocular pressure. Hyperthyroidism. Renal impairment. GI or GU obstruction. Seizure disorders. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
Antihistamine + sympathomimetic.
See Contraindications. Avoid concomitant aluminum- or magnesium-containing antacids. Pseudoephedrine: Antagonizes antihypertensives. Increased ectopic pacemaker activity with digitalis. Avoid other sympathomimetics. Fruit juices (eg, grapefruit, orange, apple) may reduce plasma levels.
Headache, insomnia, nausea, dry mouth, dyspepsia, throat irritation, dizziness, agitation, back or abdominal pain, palpitations, nervousness, anxiety, upper respiratory infection.
Tabs 24hr—100; 12hr—100, 500
Clinical Pain Advisor Articles
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Kinesiophobia May Be Associated With Greater Cutaneous Allodynia in Migraine
- PainDETECT May Not Be Optimal to Detect Neuropathic Components of Orofacial Pain
- Topical Migraine Trigger Point Treatment as Effective as Injection
- Chronic Spinal Pain and Depression: Does One Represent a Risk Factor for the Other?
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Prescription Digital Therapeutic Approved for Opioid Use Disorder
- Persistence of Post-Traumatic CRPS Associated With Initial Pain Sensitization
- Comparable Incidence, Intensity of Tourniquet Pain With Infraclavicular, Axillary Brachial Plexus Blocks
- Many Patients Withhold Information From Clinicians
- Shifting Pattern Seen for Primary Care Office Visits
- Questionnaire Reliably Predicts Effect of Migraine on Work-Related Duties
- Clinicians Must Do Their Part to Address Inaccurate Online Health Information